Dinh P, Graham JD, Elder EN, Kabir M, et al. Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing. Breast Cancer Res Treat 2021 Dec 1. pii: 10.1007/s10549-021-06456.
PMID: 34853987